These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 17459056)

  • 21. Gene amplification and overexpression of protein phosphatase 1alpha in oral squamous cell carcinoma cell lines.
    Hsu LC; Huang X; Seasholtz S; Potter DM; Gollin SM
    Oncogene; 2006 Sep; 25(40):5517-26. PubMed ID: 16619035
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Amplification and overexpression of the cyclin D1 and epidermal growth factor receptor genes in non-small-cell lung cancer. Lung Cancer Study Group.
    Reissmann PT; Koga H; Figlin RA; Holmes EC; Slamon DJ
    J Cancer Res Clin Oncol; 1999; 125(2):61-70. PubMed ID: 10190311
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MET gene copy number in non-small cell lung cancer: molecular analysis in a targeted tyrosine kinase inhibitor naïve cohort.
    Beau-Faller M; Ruppert AM; Voegeli AC; Neuville A; Meyer N; Guerin E; Legrain M; Mennecier B; Wihlm JM; Massard G; Quoix E; Oudet P; Gaub MP
    J Thorac Oncol; 2008 Apr; 3(4):331-9. PubMed ID: 18379349
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chromosome 8 copy numbers and the c-myc gene amplification in non-small cell lung cancer. Analysis by interphase cytogenetics.
    Kubokura H; Koizumi K; Yamamoto M; Tanaka S
    Nihon Ika Daigaku Zasshi; 1999 Apr; 66(2):107-12. PubMed ID: 10339988
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Amplification and overexpression of the dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 2 (DYRK2) gene in esophageal and lung adenocarcinomas.
    Miller CT; Aggarwal S; Lin TK; Dagenais SL; Contreras JI; Orringer MB; Glover TW; Beer DG; Lin L
    Cancer Res; 2003 Jul; 63(14):4136-43. PubMed ID: 12874018
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increased ALK gene copy number and amplification are frequent in non-small cell lung cancer.
    Salido M; Pijuan L; Martínez-Avilés L; Galván AB; Cañadas I; Rovira A; Zanui M; Martínez A; Longarón R; Sole F; Serrano S; Bellosillo B; Wynes MW; Albanell J; Hirsch FR; Arriola E
    J Thorac Oncol; 2011 Jan; 6(1):21-7. PubMed ID: 21107285
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification and characterization of a 19q12 amplicon in esophageal adenocarcinomas reveals cyclin E as the best candidate gene for this amplicon.
    Lin L; Prescott MS; Zhu Z; Singh P; Chun SY; Kuick RD; Hanash SM; Orringer MB; Glover TW; Beer DG
    Cancer Res; 2000 Dec; 60(24):7021-7. PubMed ID: 11156406
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Distinct outcome of stage I lung adenocarcinoma with ACTN4 cell motility gene amplification.
    Noro R; Honda K; Tsuta K; Ishii G; Maeshima AM; Miura N; Furuta K; Shibata T; Tsuda H; Ochiai A; Sakuma T; Nishijima N; Gemma A; Asamura H; Nagai K; Yamada T
    Ann Oncol; 2013 Oct; 24(10):2594-2600. PubMed ID: 23899839
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clonal MET Amplification as a Determinant of Tyrosine Kinase Inhibitor Resistance in Epidermal Growth Factor Receptor-Mutant Non-Small-Cell Lung Cancer.
    Lai GGY; Lim TH; Lim J; Liew PJR; Kwang XL; Nahar R; Aung ZW; Takano A; Lee YY; Lau DPX; Tan GS; Tan SH; Tan WL; Ang MK; Toh CK; Tan BS; Devanand A; Too CW; Gogna A; Ong BH; Koh TPT; Kanesvaran R; Ng QS; Jain A; Rajasekaran T; Yuan J; Lim TKH; Lim AST; Hillmer AM; Lim WT; Iyer NG; Tam WL; Zhai W; Tan EH; Tan DSW
    J Clin Oncol; 2019 Apr; 37(11):876-884. PubMed ID: 30676858
    [TBL] [Abstract][Full Text] [Related]  

  • 30. PPAPDC1B and WHSC1L1 are common drivers of the 8p11-12 amplicon, not only in breast tumors but also in pancreatic adenocarcinomas and lung tumors.
    Mahmood SF; Gruel N; Nicolle R; Chapeaublanc E; Delattre O; Radvanyi F; Bernard-Pierrot I
    Am J Pathol; 2013 Nov; 183(5):1634-1644. PubMed ID: 24051013
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lung cancer cell lines harboring MET gene amplification are dependent on Met for growth and survival.
    Lutterbach B; Zeng Q; Davis LJ; Hatch H; Hang G; Kohl NE; Gibbs JB; Pan BS
    Cancer Res; 2007 Mar; 67(5):2081-8. PubMed ID: 17332337
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunohistochemical overexpression of platelet-derived growth factor receptor-beta (PDGFR-β) is associated with PDGFRB gene copy number gain in sarcomatoid non-small-cell lung cancer.
    Tsao AS; Wei W; Kuhn E; Spencer L; Solis LM; Suraokar M; Lee JJ; Hong WK; Wistuba II
    Clin Lung Cancer; 2011 Nov; 12(6):369-74. PubMed ID: 21729646
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression of Her-2/neu in human lung cancer cell lines by immunohistochemistry and fluorescence in situ hybridization and its relationship to in vitro cytotoxicity by trastuzumab and chemotherapeutic agents.
    Bunn PA; Helfrich B; Soriano AF; Franklin WA; Varella-Garcia M; Hirsch FR; Baron A; Zeng C; Chan DC
    Clin Cancer Res; 2001 Oct; 7(10):3239-50. PubMed ID: 11595720
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Relations of the c-myc gene and chromosome 8 in non-small cell lung cancer: analysis by fluorescence in situ hybridization.
    Kubokura H; Tenjin T; Akiyama H; Koizumi K; Nishimura H; Yamamoto M; Tanaka S
    Ann Thorac Cardiovasc Surg; 2001 Aug; 7(4):197-203. PubMed ID: 11578259
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Epidermal growth factor receptor in non-small-cell lung carcinomas: correlation between gene copy number and protein expression and impact on prognosis.
    Hirsch FR; Varella-Garcia M; Bunn PA; Di Maria MV; Veve R; Bremmes RM; Barón AE; Zeng C; Franklin WA
    J Clin Oncol; 2003 Oct; 21(20):3798-807. PubMed ID: 12953099
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The candidate oncogene (MCRS1) promotes the growth of human lung cancer cells via the miR-155-Rb1 pathway.
    Liu M; Zhou K; Huang Y; Cao Y
    J Exp Clin Cancer Res; 2015 Oct; 34():121. PubMed ID: 26467212
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [EGFR and HER2 gene expression status and their correlation in non-small cell lung cancer].
    Zeng X; Wu SF; Zhou WX; Li DJ; Gao J; Liang ZY; Liu TH
    Zhonghua Bing Li Xue Za Zhi; 2006 Jul; 35(7):398-402. PubMed ID: 17069674
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Acquirement of DNA copy number variations in non-small cell lung cancer metastasis to the brain.
    Li F; Sun L; Zhang S
    Oncol Rep; 2015 Oct; 34(4):1701-7. PubMed ID: 26259861
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Different pattern of expression of cellular oncogenes in human non-small-cell lung cancer cell lines.
    Kiefer PE; Wegmann B; Bacher M; Erbil C; Heidtmann H; Havemann K
    J Cancer Res Clin Oncol; 1990; 116(1):29-37. PubMed ID: 1690210
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A comprehensive search for DNA amplification in lung cancer identifies inhibitors of apoptosis cIAP1 and cIAP2 as candidate oncogenes.
    Dai Z; Zhu WG; Morrison CD; Brena RM; Smiraglia DJ; Raval A; Wu YZ; Rush LJ; Ross P; Molina JR; Otterson GA; Plass C
    Hum Mol Genet; 2003 Apr; 12(7):791-801. PubMed ID: 12651874
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.